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Abstract
Background: The Individualised Neuromuscular Quality of Life (INQoL) questionnaire is a published muscle disease
specific measure of QoL that has been validated using both qualitative and quantitative methods in a United
Kingdom population of adults with muscle disease. If INQoL is to be used in other countries it needs to be
linguistically and culturally validated for those countries. It may be important to understand any cultural differences
in how patients rate their QoL when applying QoL measures in multi-national clinical trials.
Methods: We conducted a postal survey of QoL issues in US adults with muscle disease using an agreed
translation, from UK to US English, of the same questionnaire as was used in the original construction of INQoL.
This questionnaire included an opportunity for free text comments on any aspects of QoL that might not have
been covered by the questionnaire. We examined the responses using both quantitative and qualitative
approaches. The frequency of the responses in US versus UK populations was compared using appropriate
correlation tests and Rasch analysis. A phenomenological approach was used to guide the qualitative analysis and
facilitate the exploration of patients’ perceptions and experiences.
Results: The US survey received 333 responses which were compared with 251 UK survey responses.
We found that INQoL domains covered all the issues raised by US subjects with no additional domains required.
The experiences of those with muscle disease were remarkably similar in the US and UK but there were differences
related to the impact of muscle disease on relationships and on employment which was greater for those living in
the United States. The greater impact on employment was associated with a higher importance rating given to
employment in the US. This may reflect the lower level of financial support for those who are unemployed, and
the loss of employment related health benefits.
Conclusions: INQoL is appropriate for use in US population but there may be differences in the importance that
US subject attach to certain aspects of QoL that could be the basis for further study.
If these differences are confirmed then this may have implications for the interpretation of QoL outcomes in multi-
national trials.
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Muscle diseases (MD) are a group of conditions that can
be acquired or genetic and which result in progressive
shrinking and weakness of the skeletal muscle such as
to cause varying degrees of disability. The individual
muscle diseases differ in their age of onset, their rate of
progression and their pattern of weakness which in turn
dictates the nature and extent of the disability that they
cause. The disability caused by MD impacts upon qual-
ity of life. The Individualised Neuromuscular Quality of
Life (INQoL) questionnaire is a MD specific measure of
QoL that has been validated using a UK population [1].
The construction of INQoL was based upon both quali-
tative and quantitative methods which established the
face, content and construct validity, the reliability (test
re-test) and to some extent the responsiveness of
INQoL. Because QoL is a patient reported subjective
measure it is important to ensure that it remains valid
when used in countries other than the UK where lan-
guage and culture vary. In order to achieve this linguis-
t i ca n dc u l t u r a lv a l i d i t yf o rt h eu s eo fI N Q o Lf o rM D
patients in the United States, we needed to first agree
upon an American English translation. We also needed
to ensure that the QoL domains identified in the UK
research were also appropriate for patients from the
United States and check that there were no additional
domains that might require inclusion. Most publications
on the differences in QoL between countries have
focussed on validation of questionnaires across different
countries rather than the actual difference in percep-
tions of QoL in different countries for a given disease
[2-6]. There has been no direct comparison of QoL
issues for MD in different countries. In performing our
primary process of linguistic and cultural validation of
INQoL for use in the United States we gained a unique
opportunity to contrast and compare the UK and US
experiences of those with MD and take this opportunity
to present these results.
Although the use of validated QoL scales in MD does
allow the collection of quantitative data that can be
used in clinical studies and therapeutic trials, the pro-
cess of reducing QoL to simple figures may obscure the
experience of how living with MD really affects people.
Qualitative research such as that required for the con-
struction of questionnaires like INQoL does allow a clo-
ser appreciation of individuals’ experiences of living with
chronic disease and disability [7-9]. We therefore take
this opportunity to report the verbal and written com-
ments from both UK and US patients that provide
unique insights into the actual impact of MD on their
lives. While the UK quotes were the subject of qualita-
tive analysis for the construction of the original INQoL,
they have not been previously reported verbatim.
Methods
UK patients were recruited from the MD clinic of King’s
College Hospital and from two UK muscle patient sup-
port groups. US patients were recruited from the muscle
clinics of three US centres. Patients were eligible to take
part in the study if their MD had been symptomatic for
at least six months. MD diagnoses were confirmed
through expert opinion using standard diagnostic cri-
teria and confirmatory testing, including where appro-
priate molecular genetic analysis, serum creatine kinase
levels, clinical neurophysiology studies, or muscle
biopsy. Patients had to be aged 16 years and above and
literate in English. Patients with major co-morbidity
from other active cardiac, respiratory or rheumatologic
disorders which would affect quality of life were
excluded.
Patients were sent a questionnaire designed around
the life domains that had been identified during the ori-
ginal UK semi-structured interviews [1]. For each
domain there were closed ended questions asking the
extent to which their MD affected this domain (on a
five point Likert scale from ‘n o ta ta l l ’ affected to ‘very
much’ affected) and the importance that they attached
to this impact (on a five point Likert scale, ranging from
‘not at all important’ to ‘extremely important’). We also
asked whether the impact was “good” or “bad” and
encouraged free text comments on the impact of MD
on these life domains to allow respondents to provide
greater detail of their experiences and include informa-
tion not tapped by the close ended questions. The UK
version of this questionnaire was independently con-
verted into US English by the principal investigators
from each of the three US centres (SP, JTK, CJ). Each
US investigator then returned their version to the UK
investigators (MR, VB) who collated the different ver-
sions, and resolved any inconsistencies by group discus-
sion between all US and UK investigators to reach a
consensus. Examples of divergence from the UK version
included word changes such as; “tick” changed to
“check”, “stick” changed to “cane” and “colleague” chan-
ged to “co-worker”.
We also collected data for respondents’ gender, age
and muscle disease diagnosis. The questionnaires were
sent with a prepaid envelope for return. Non-responders
were sent another questionnaire two weeks later and
further non-responders were sent a reminder letter one
week later. The study had Institutional Review Board
approval from all the institutions involved.
Analysis
For each life domain we compared the frequency distri-
bution of UK versus US responses for both the extent of
the impact and the importance of the impact. We also
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order to the product of the two factors (extent and
importance) giving an overall impact scale from 1 to 9.
Due to relatively large sample size and normal distribu-
tion we anticipated there would not be any difference
between results of parametric and corresponding non-
parametric tests; this was in fact the case. Thus para-
metric unpaired t-test analysis was performed to com-
pare UK and US responses. Chi squared test was used
to compare the UK and US responses for the direction
of the impact, as good or bad. We performed Rasch
analysis to examine the psychometric properties of the
questionnaire in US and UK populations. In this model,
responses to each question have a probabilistic correla-
tion with the difficulty of the question [10]. We calcu-
lated fit of the observed data to the Rasch model and
compared responses to questions in UK and US popula-
tions. In the course of the original UK construction of
INQoL, interviews with 41 subjects were tape recorded
and transcribed [1]. A phenomenological approach was
used to guide the analysis and facilitate the exploration
of patients’ perceptions and experiences [8,11]. Themes
were extracted and clustered together into categories
representing life domains influenced by MD. A coding
scheme was devised to represent the individual domain
and sub-domain categories and this was applied to the
data. Finally the validity of the coding scheme was veri-
fied through an external inspection by a second categor-
izer (AJC) who applied the scheme to a sample of
interviews. We applied the same coding scheme to the
free text comments given to us by both the UK and US
respondents of the postal questionnaire. SPSS for Win-
dows version 15.0 was used for statistical tests and Win-
step version 3.68.2 was used to do the Rasch analysis.
Results
The UK survey received 251 responses (response rate
47%) comprising 90 males and 161 females (ratio 1:2.8)
ages 16- 96 (mean age 52.61, SD = 15.95). The US sur-
vey received 333 responses of which 10 had to be
excluded because of missing data (effective response
rate 50%). This sample comprised 176 males and 147
females (ratio 1.19:1) ages 18- 84 (mean age 50.15 years
SD = 16.16) (Table 1). Diseases represented in both UK
and US samples included congenital myopathies, limb
girdle muscular dystrophies, facioscapulohumeral mus-
cular dystrophy, dystrophic and non-dystrophic myoto-
nias and inflammatory myopathies.
Quantitative data
The percentage of UK and US patients scoring some
impact (i.e. scoring 2 to 5 for extent of impact), or no
impact (scoring 1) for each of the domains is given in
Figure 1. For the UK population the percentage
reporting some impact ranged from 45% for Work to
96% for both Activities of Daily Living (ADL) and the
Social and Leisure domain. For the US population the
percentage reporting some impact ranged from 65% for
Relationship with others to 94% for ADL.
Table 2 gives the impact scores (extent of impact,
importance of impact and overall impact) for each of
the life domains and the results of the significance tests
between the UK and US samples. The overall impor-
tance score of all the relationship domains (Friends,
Family, Others and Partners) were significantly higher in
US patients compared to UK patients. This difference
was not due to any difference in the extent of the
impact but was due to there being a greater importance
attached to the impact of MD on relationships by the
US patients. US respondents scored a significantly
higher impact in the Employment domain. For all
domains the direction of the impact was negative for
the majority of both UK and US respondents. What was
interesting was that there was a significant minority who
reported a positive impact of their muscle disease on
relationships. (Figure 2).
Since the UK and US populations differed in gender
distribution we performed unpaired t-test to explore the
effects of gender on the responses. For all domains
except “Body Image” males had higher impact scores
compared to females. Females reported a significantly
higher impact of their MD on “Body Image” domain
than did males (Overall Impact score: mean female rank
260.7 versus male rank 218.48; P = 0.001). When this
was separated out to look at UK and UK samples, UK
female patients had higher impact on body image
domain than UK male patients (P = 0.001); however
there was no significant difference between US female
and male patients. There was also no significant differ-
ence between UK and US female patients in body image
impact score; but US male patients had a higher impact
on body image than UK male patients (P = 0.005). The
difference between body image scores in two popula-
tions is reduced by mixing UK male and female patients.
Performing ANCOVA test considering gender as a
Table 1 Patient Demographics
Country Gender n Age
Average (SD)
UK Male 64 55.61 (16.13)
Female 182 51.48 (15.77)
Total 249 52.62 (15.95)
US Male 172 48.01 (16.69)
Female 146 52.29 (15.41)
Total 328 50.15 (16.16)
Total 577 51.22 (16.12)
SD: standard deviation
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ference in the two populations, and showed that the
higher impact on employment and relationships in the
US population remained and was therefore independent
of the gender ratio difference: Employment (F = 25.925,
P < 0.001), Relationships with friends (F = 14.865, P <
0.001), Family relationships (F = 12.529, P < 0.001),
Relationship (partner) (F = 22.127, P < 0.001), Relation-
ships with others (F = 10.312, P < 0.001), Body image (F
= 8.926, P < 0.001), Perceptions of the future (F = 7.091,
P = 0.001)).
We also explored the possible impact of age on
impact scores by splitting the sample into those under
and over 50 years-old. Those over 50 years-old had
higher scores for all domains with the exception of the
domain “Employment” for which those under 50 years-
old scored a higher impact (Overall Impact score: mean
rank for younger patients 220.46 and older patients
168.96; P value < 0.001).
Rasch analsys
Rasch analysis gives outfit mean square values (msnq).
Outfit msnq values represent the proportion of items
“out of range” ie for which there is a higher proportion
of “easy” or “difficult” responses than expected. Mean
squares values between 0.70 and 1.50 are accepted as
reasonably fit in psychological studies. On the whole,
the questionnaire had very good outfit msnq (1.12).
However the questionnaire items relating to “Work
importance” and “Work impact” had outfit msnq values
of 2.36 and 2.06 respectively meaning that they were the
most “difficult” items for participants to endorse. This
was mainly due to the effect of UK responses to the
employment question as 106 patients (42% of UK popu-
lation) answered “Employment importance” and
“Employment impact” as “not important at all” as shown
in Figure 3.
Qualitative data
Table 3 summarises the specific issues raised by these
patients and how they were clustered into the domains
and sub-domains used for INQoL. The US respon-
dents’ free text comments gave them an opportunity to
raise specific issues outside of the closed ended ques-
tions. In general these free text comments reflected
issues already raised by UK patients and therefore
already encompassed by the existing INQoL domains.
Where additional specific issues were raised by US
respondents, these also fitted into the existing
domains. The quotes of patients illustrate the issues
explored by INQoL, and provide insight into the real
impact that MD has on these patients. In some cases
the quotes from UK and US patients are remarkably
similar. All the UK quotes including those in the sam-
ple given here were the ones grouped into the broad
domains that made up the final INQoL UK question-
naire. These domains clearly corresponded across the
UK and US surveys.
Figure 1 The percentage of UK and US respondents endorsing some impact of their muscle disease on each of the life domains.
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Remarks about daily activities ranged from those about
personal care to others about housework, getting around
and shopping. To some extent the functional effects of
muscle weakness on daily activities were predictable and
easily related to the likely distribution of weakness in
these patients. This quote
“I do have problems still when blow-drying my hair.
When I hold the hairdryer for a long period, my arms
start to feel heavy and tired.” - UK patient
reflects proximal upper limb weakness while this one
“Difficulty in getting from a sitting position to a stand-
ing position, difficulty in retrieving an object off the floor,
difficulty in use of fingers to grip objects, to write a letter,
to do personal hygiene, difficulty walking without aid
and decreased stamina when ambulating for long peri-
ods of time (20-30 min).” - US patient
reflects mostly proximal lower limb weakness but with
some hand weakness also. What may be less appreciated
by medical professionals is the degree to which fatigue
and pain impact upon daily activities as evidenced by
two similar quotes from UK and US patients;
“I do not have the strength/energy to sustain normal day-
to-day living activities for more than a couple of hours. I
become overwhelmingly tired and my muscles ache so
much I cannot do anything or even concentrate on seden-
tary activities. This is despite painkillers. I only recover
after lying down for a couple of hours. It takes so much
effort to get through the basic needs of living that there is
no energy/time left for social activities. The almost constant
pain affects concentration too.” -U Kp a t i e n t
Table 2 Descriptive data for domain scores from United
Kingdom (UK) and United States of America (US)
Extent Importance Overall
Mean SD Mean SD Mean SD
Daily activities UK 3.84 1.10 3.88 1.14 6.74 2.10
US 3.65 1.17 3.92 1.00 6.76 1.73
Employment UK 2.69* 1.76 2.68* 1.77 4.36* 3.48
US 3.78 1.38 4.20 0.92 7.37 1.70
Social activities UK 3.96* 1.13 3.80 1.17 6.76 2.18
US 3.67 1.23 3.91 0.99 6.78 1.83
Relationships (friends) UK 2.56 1.36 2.71* 1.48 4.27* 2.72
US 2.60 1.35 3.35 1.22 5.43 2.15
Relationships (family) UK 2.82 1.49 3.03* 1.59 4.84* 2.94
US 2.71 1.44 3.73 1.13 6.04 2.07
Relationships (partner) UK 2.66* 1.62 2.92* 1.76 4.56* 3.28
US 3.15 1.48 4.05 1.08 6.70 1.98
Relationships (others) UK 2.60 1.44 2.63* 1.46 4.23* 2.81
US 2.45 1.33 3.33 1.17 5.26 2.14
Independence UK 3.78* 1.42 4.05 1.34 6.81 2.65
US 3.54 1.39 4.13 1.06 7.00 1.95
Emotions UK 3.73 1.27 3.77 1.27 6.50 2.41
US 3.38 1.36 3.84 1.09 6.50 2.07
Body image UK 3.36 1.46 3.21 1.41 5.55 2.76
US 3.06 1.45 3.47 1.21 6.00 2.29
Perceptions of the future UK 4.13 1.07 4.07 1.13 7.19 2.06
US 3.92 1.26 4.15 1.02 7.28 1.91
Extent column: Extent of Impact (minimum 1 and maximum 5); Importance
column: Importance of impact (minimum 1 and maximum 5); Overall column:
Overall impact (minimum 1 and maximum 9)
* significantly different (P < 0.01) (unpaired t- test)
SD: Standard deviation
Figure 2 The percentage of the UK and the US samples endorsing the direction of impact as being “Good” for each of the domains.
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social functions, around 2-3 pm, I fall asleep.” -U S
patient
Employment
Many comments were made about respondents’ working
life. These related not only to the effects of MD upon
working activities but also upon job prospects;
“I was made redundant three years ago when the com-
pany I had worked with for 17 years relocated. I firmly
believe that the reason I was not able to get another per-
manent job was because of my condition.” - UK patient
“I lost my job due to weakness & fatigue. Most of my
co-workers were working 12 hour shifts. There is no way
I could do that. I loved my job & did not want to go on
disability (benefits)."-UK patient
Many respondents commented on their having to take
early retirement on ill health grounds, or upon the
adaptations they had made to their jobs or career path.
The impact of stopping work upon self-identity was
clear;
“(I) Had to retire from work at age 35 - (this) had a
huge impact on how I saw myself as a contributing
member of society.” - UK patient
“(I) Had to retire at 53 because of my muscle problems
- loss of 60% of my income & my health insurance was
cancelled after 30 years at the same company.” -U S
patient
Social and leisure activities
Respondents also commented upon the impact of their
condition upon leisure and social activities. Both sport-
ing and sedentary activities were influenced. Difficulties
socialising and visiting friends and family were com-
monly reported and these were linked to transport pro-
blems and difficulties in accessing buildings and homes;
“This illness affects all my leisure activities, as I’mi na
wheelchair. I’ve had to give up dancing, gardening and
even visiting friends and shopping. Even my son and
daughter I cannot visit as there are steps which I cannot
get up over. Some shops have a ramp or are level but a lot
aren’t. I have been confined to the house for 5 months due
to the fact I could no longer transfer from the car to my
wheelchair. After 5 months of worry and expense we have
just had a car converted for me to drive.” -U Kp a t i e n t
“It’s hard to do some of the things I like to do, like go
for walks, ride bike and hang out with my friends.” US
patient
UK/US respondents 
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Figure 3 Showing how UK and US sample differed in their responses for question 2C; “How important is the effect of your muscle
disease on employment”.
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Page 6 of 12Table 3 The specific issues raised by the UK & US patients with muscle disease showing how these have been
grouped into sub-domains and domains used by INQoL
Domain Sub domain Specific Issues raised by patients
Activities Daily activities Getting out and about (transport & driving)
Self care
Housework
Falling
Leisure Sport
Eating out
Sedentary hobbies
Visiting friends & family
Gardening
Shopping
Holidays/vacation
Employment Work activities
Stopping work
Limitations to career/job prospects
Discrimination
Change in job/occupation
Financial considerations
Social impact Partner Meeting potential partner
Strain on relationships
Sex life
Support from partner (positive)
Limits on doing activities with partner
Family Lack of support
Worry about being a burden
Worry about passing on gene
Support from family (positive)
Lack of understanding
Limits on participation
Friends Difficulty in visiting friends
Loss of contact
Support from friends (positive)
General social
interaction
Avoidance of situation
Lack of understanding
Difficulty explaining condition
Other people’s perceptions
Problems of access
Discrimination
Encouragement from others (positive)
Hidden disease
Other people’s emotions
Difficult to plan (unpredictable)
Psychological
Impact
Emotions Feelings of loss
Feelings of abandonment
Guilt
- at not being able to fulfil social role
- at passing on gene to children
Depression
Frustration
Sadness
Anxiety
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Some respondents commented that friendships had
faded as a result of the difficulties in taking part in
activities previously shared with friends;
“A lot of “friends” simply drift away when it is obvious
there is a chronic condition which is unlikely to change,
and when one can no longer go out and about to mutual
interests or be relied on to entertain at home. Someone
who would rather go to bed than even sit and talk
becomes of little interest to any but the most long suffer-
ing of friends.” UK patient.
Many respondents felt that there was a lack of understand-
ing about MD and its effects. This made the condition diffi-
cult to explain. In particular patients with myositis frequently
commented upon the difficulty they had in explaining their
condition to other people. This was believed to be due to
their appearance of physical well-being;
“The main problems lie with the condition not showing
any visible signs and symptoms and often having to
explain oneself or making excuses for inabilities.” -U K
patient
“Many people do not see my handicap on the surface.
My job does not entail heavy lifting, getting up and
down heavy stairs or ladders, so many do not know of
my handicap. Only when we are invited to participate in
activities where there will be physical activity will I
make excuses not to.” - US patient
Some patients also commented upon the lack of
understanding about their condition, not only in other
people but also in the in medical profession. This was a
source of great distress;
“They and also medical staff have never heard of
“Inclusion Body Myositis” - UK patient
“You’re not that bad.” -U Sp a t i e n tr e f e r r i n gt oc o m -
ments about relationships & social interaction.
“Most people don’t understand Inclusion Body Myosi-
tis. Of course, this is also true of doctors” - US patient.
Family
An immediate effect upon some respondents’ behaviour
towards their family was evident;
“I find myself distancing myself from my family. If I am
too caring I may be expected to physically do something
T a b l e3T h es p e c i f i ci s s u e sr a i s e db yt h eU K&U Sp a t i e n ts with muscle disease showing how these have been
grouped into sub-domains and domains used by INQoL (Continued)
Fear
Shame/embarrassment/self-conscious
Loneliness
Perception of the
future
Fear of losing independence
Fear of passing on gene to children (congenital patients)
Awareness that future is uncertain
Identity/Self-image Body image
Social image/identity/role
Independence Loss of control
Coping strategies Determination
Acceptance
- of condition
- that no treatment available
Focusing on the present
Making the best
Taking control
Changing expectations
Planning
Religious faith
Social comparison
Avoidance of situations/people/places
Covering effects of condition
Attempts to carry on as before
Avoidance of specific entities that are believed to worsen condition (stress, people with infections,
pollen, extreme temperatures)
Hope for the future
Pacing self/resting to adapt to tiredness/adjust to accommodate
The specific issues raised by the US population given in bold italics are different to those raised by UK subject but fit within the existing sub-domains and
domains as shown.
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though I suffered for it- their needs were met whilst I
cried alone in pain. I’m continually trying to balance my
relationships but this year have felt, I just want to be left
alone so that I can at least cope and have enough energy
to be reasonably cheerful and good company for my hus-
band who I am sure you appreciate has had a lot to
cope with himself. To be honest I don’t answer the phone
or the door while my husband is at work and when he
comes home I let him do it.” - UK patient
“Due to my limits I find I am a bit more concerned
about my relationships with other close family members.
I require more from them.” - US patient.
Problems of access to the homes of friends and family
and to social venues were also a source of difficulty for
relationships.
Partners
A large proportion of the respondents commented upon
the impact their condition had exerted on their relation-
ship with their spouse or partner;
“My muscle condition, weakness (and) tiredness
destroyed my marriage in the end. I’m now on my own
and can see no future with myself ever having a relation-
ship with anyone ever again, it’sj u s tt o oh a r d . ” -U K
patient.
“My spouse divorced me. It’s been about two months.
We were married for 24 years.” - US patient
“We don’t share activities any more, we can’tg oo n
same kind of holidays we used to, I’man u i s a n c ew h e n
we go out together, and I’ve gone off sex completely. I
can’t see why he still bothers with me.” - UK patient
“How could it not affect spouse. Walking slowly, vaca-
tion planning, lack of spousal relationships, loss of 60%
income - wife had to go back to work & my only son just
started college.” - US patient.
A number of respondents also commented upon the
difficulties they had in meeting potential partners;
“When it comes to a partner, everything is fine until I
mention my illness, in which case they don’tw a n tt o
know.” - UK patient
“I am filing for a not to be with my wife & I am having
a hard time with getting or staying with someone
because of this.” - US patient
However, the support provided by respondents’
families and partners was also clear from a number of
comments;
“When I finally get diagnosed my fiancé and friends
were really supportive and helped me to get through the
most difficult times.” - UK patient
“My family & friends are very supportive of my MD in
that they help with stairs, getting up from chairs etc.” -
US patient
The themes relating to emotions and other psycholo-
gical issues were very much intertwined and
respondents tended to comment upon the emotional
impact of MD in the context of the other life domains.
For example, patients’ fears about the future had a con-
siderable impact upon the emotional feelings expressed.
Independence
Independence was alluded to a great deal by both UK
and US subjects;
“I have to totally depend on others for just about
everything. I can use my hands to eat and drive my
mobile chair. I can’t comb my own hair; I need help to
take a bath, use the toilet and to get in and out of bed.
Also to sit up. I am totally dependent on others. I can
take my own medicine whilst sitting.” - US patient
Independence was sometimes mentioned with particu-
lar reference to one’s spouse;
“I am very dependent on my husband and this affects
me emotionally. I feel a burden sometimes, although he
doesn’t complain.” - UK patient
Independence was also intertwined with perceptions
about appearance, fears about the future and religiosity
as coping strategy;.
“My independence is gone, that is what hurts most of
all. I used to be proud of the way I used to look, but not
now with my weight loss. The little use of my hands, feet,
throat and neck control, it’s hard to think of what the
future might bring. I just ask my Lord to walk with me
and help me carry on”... - US patient
“Sometimes I feel well bal a n c e da n dh a p p ya n dy e t
other times I feel sad and lonely even though I have a
wonderful family. I picture my future as being on my
own, ill and more dependent than I am now, but I try
not to think about the future.” - UK patient
Perceptions of the future
Patient’s perceptions of the future were linked to
becoming a burden on family;
“My thoughts about the future are very fearful. I know
this illness is supposed to be slow in progressing, but how
slow? At the moment I can only stand for a few seconds
and if I dare bend my knees I’m on the floor in one
untidy heap and can only get up with my husband’s
help (and) with a hoist. So I cannot walk or stand. I can-
not lift my head off the pillow when I’mi nb e da n di t ’s
very difficult to turn over in bed... what happens if I get
worse. My husband is seventy-five. What will happen if
he dies?” - UK patient
“What future independence! I’ll be getting weaker and
end up in a wheelchair with people waiting on me.” -U S
patient
Other concerns about the future related to the genetic
nature of some muscle diseases. A number of respon-
dents were worried about the possibility that they had
passed on their condition to their children. They also
had concerns about being able to physically care for
their children in the future;
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will become to my family, my wife especially, as I get
more immobile. Also I worry a great deal about what I
have passed onto my daughter. They learnt about genet-
ics at school, so they know that it is passed on, but I was
told by a doctor at an FSH (facioscapulohumeral muscu-
lar dystrophy) get together not to have them tested unless
it was absolutely necessary as the tests were not always
conclusive.” - UK patient
“I have a little boy, who I feel may have my condition
or worse. I can’t imagine how hard it would be for me to
take care of him if my condition should happen to wor-
sen. That is my everyday worry - towards the future.” -
US patient
Self Image, identity and body image
MD itself, but also its treatment, had effects on actual
physical appearance;
“I hate the way long-term steroid medication has made
me look. I cannot bear to look in a mirror and I just
cannot look at photos of myself taken before my condi-
tion.” - UK patient
In other cases the effect on body image was more to
do with the way it affected one’s mobility;
“If e e ll i k eas e c o n dc l a s sc i t i z e na sIu s eaw a l k e r
and I feel like people are looking down on me because I
have a problem walking and getting around.” -U S
patient
Loss of independence and its consequent dependence
on others had a considerable impact upon patients’ self-
image and sense of identity;
“Id o n ’t really have any independence. I think I must
have lost the will to even want to be independent. I don’t
feel like I’m a person any more- maybe just an extension
of my husband most of the time, which is not so bad
because he’s a really nice guy!” - UK patient
Subjects’ perceived poor body image could also contri-
bute to social isolation;
“(I) Stay away from people that know about my condi-
tion, then I am just me.” - US patient
Sex
The impact of MD upon body image also had implica-
tions for social and sexual confidence;
“I’m very self-conscious when it comes to the sex side of
the relationship and I want to hide myself as much as
possible. Consequently I find myself “putting off” the phy-
sical side of the relationship and so not encourage it
even though we both still enjoy it when it does happen.
I’m a bit overweight because of lack of exercise so I am
trying to cut down my intake of food.” - UK patient
Physical impairments also made sexual activity diffi-
cult for some;
“The only deleterious effect on my relationships has to
do with my wife. It prevents me from being as agile as I
would prefer during sex.” UK patient
Coping
A variety of recognised coping strategies were employed
by those with MD. These included a) planning;
“Because of the condition it is not easy to do things on
the spur of the moment. It is not always practical to go
to places that are new to me without a bit of forward
planning. For example, are there stairs or lifts, how far is
it to walk, what is the ground like?” - UK patient
“...when I fly I order a town car to take me to the air-
port, I order a wheelchair to be waiting at the church
and order another for my destination... I get into a car
better on the driver’s side, so I request that I sit behind
the driver...” - US patient
b) focusing on the immediate day to day issues with a
element of denial of the future;
“The future frightens me, so I have trained myself not
to think too far ahead and to enjoy what independence I
have today.” - UK patient
“I live day by day and am doing fine.” UK patient
c) comparing one’s self with less fortunate individuals;
“However, I consider myself blessed and try to use my
heart to be of help to others in worse shape than I.” -U S
patient
“After reading what other folk have gone through I feel
very fortunate to be as healthy as I am.” - UK patient
d) remaining optimistic;
“I am optimistic about the future, which will involve
study, more sedentary hobbies and refusing to be beaten
by this disease.” - UK patient
“Well I am a complete optimist and I go day by day so
I feel rather good on emotion since I don’t get as much
pain as I used to and I can handle the tremor. I am
doing all right.” - US patient
e) acceptance and changing expectations;
“One has to accept that there are many things one can
no longer do- if these are very important one has to ask
for help- if not the there is a conscious decision to do
without or accept a lowering of expectations and a com-
p r o m i s eo np r e v i o u s l ya c c e p t a b l es t a n d a r d s . ” -U K
patient
f) religion;
“At the age of 72, my best way to maintain peace/com-
fort is with my good wife and prayer.” UK patient
Discussion
The results of this analysis show that the quality of life
domains used by INQoL effectively captures the experi-
ences of both UK and US patients with MD. The quan-
titative data shows that all the domains were embraced
by US patients as they were by UK patients. The quali-
tative data suggests that the issues raised by both UK
and US populations are very similar and no new items
were identified by the US survey that could not reason-
ably be fitted into the domains already chosen. As with
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questions about the generalisability of our findings but
the sample sizes are large for these rare diseases and the
findings are in accordance with our clinical experience.
For the majority of both UK and US patients muscle
disease had a detrimental effect on quality of life
domains but a significant minority reported a beneficial
effect on relationships. In interviews this minority
reported that their muscle disease had made them closer
to family and friends for a variety of reasons.
The significant quantitative differences in the domain
impact responses between the two countries are of
interest but cannot be assumed to be simply due to
cross cultural differences. There are a number of poten-
tial differences between the UK and US populations that
may have accounted for different response rates. One
known difference between the UK and US populations
is gender distribution. Our analysis suggests that this
may explain some of the differences in that males scored
a higher impact for most domains than did females with
the exception of “Body Image” where females scored
higher. The two samples were fairly similar in age distri-
bution and so the differences in responses we found
between those under and over 50 years-old seem unli-
kely to account for any difference in responses of the
UK versus US populations’ responses. Similar issues
were raised in a study of the effect of epilepsy on psy-
cho-social factors which showed US, New Zealand and
UK subjects had some different scores but that interpre-
tation of these was confounded by various demographic
variables and the unknown differences in the type and
severity of the epilepsy in the three national groups [12].
Other important factors to consider would be the
distribution of specific muscle disease diagnoses, and
the range of muscle disease severity. The UK and US
population were recruited in different ways which is
likely to have led to differences in disease distribution
and severity. Such differences may have had an impor-
tant bearing upon interpretation of any differences in
impact scores not just those between countries but
also those between other groups such as gender. That
females report more impact of their MD on Body
Image might be considered not surprising. However, in
order to fully appreciate whether this is a true gender
difference, one would have to take account of the spe-
cific muscle diseases present in the male and female
populations and the severity of such diseases. Some
muscle diseases have more obvious effect on Body
Image than others. Facial features such as facial weak-
ness in facioscapulohumeral dystrophy, or ptosis in
myotonic dystrophy may mean these diseases impact
more on Body Image than does limb girdle muscular
dystrophy which usually has no facial involvement.
Inflammatory muscle diseases are treated with steroids
which may have side effects such as weight gain, moon
face, hirsuitism, and buffalo hump that may dispropor-
t i o n a t e l ya f f e c tB o d yI m a g e .M o r es e v e r em u s c l ed i s -
ease affects the gait and movements generally and can
of course mean that one is obliged to use a wheelchair.
Some patients referred to these aspects when explain-
ing the impact of their MD on Body Image.
If however the differences in disease impact recorded
by UK and US populations reflect true cross cultural
differences, this raises further interesting questions for
research. The greater importance that the US population
attaches to Relations with family and friends may reflect
differing societal values. The lesser impact of muscle
disease on Employment in the UK may be due to the
fact that unemployed UK patients are better supported
by the social security system such that lack of employ-
ment has less impact and importance for them. Conver-
sely we had expected some differences between the UK
and the US that did not in fact materialise. The impact
of muscle disease on Activities was the same for UK
and US despite the longer duration of disability access
legislation in the US and the higher proportion of spa-
cious urban living in the US as compared with the
higher proportion of crowded city living in the UK. The
influence of differences in health care systems, social
care, support networks and cultural perceptions on QoL
in different countries could be the subject of further
illuminating research. Lessons from different countries
might then shape public and social policy for the benefit
of those with MD.
A practical challenge that arises from any future MD
research in this field concerns the heterogeneity of MD.
Collectively MD is common but it is made up of a vari-
ety of individual diseases each of which may each be
rare. It is reasonable to study them collectively as all
MD may have common symptoms of weakness, fatigue,
or pain and doing so means one can obtain sufficient
numbers for quantitative research. However the indivi-
dual MDs do differ in their age of onset, distribution of
weakness, speed of progression and severity of symp-
toms. For some questions controlling for all these fac-
tors in future research may be challenging. Only future
research will tell us to what degree lumping or splitting
of the muscle diseases is required for quality of life
research.
Conclusions
INQoL is appropriate for use in US population but there
may be differences in the importance that US subject
attach to certain aspects of QoL that could be the basis
for further study.
If these differences are confirmed then this may have
implications for the interpretation of QoL outcomes in
multi-national trials.
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